Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 779-785

  Cattelan, Anna Maria ^a   Calabrò, Maria Luisa ^a   De Rossi, Anita ^a   Aversa, Savina Maria Luciana ^a   Barbierato, Massimo ^a   Trevenzoli, Marco ^a   Gasperini, Paola ^a   Zanchetta, Marisa ^a   Cadrobbi, Paolo ^a   Monfardini, Silvio ^a   Chieco Bianchi, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

HAART; HHV 8; HIV 1; Kaposi's sarcoma; Long term follow up

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS DNA; VIRUS RNA;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DRUG EFFECT; FOLLOW UP; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; MALE; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FOLLOW-UP STUDIES; HERPESVIRUS 8, HUMAN; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SARCOMA, KAPOSI; TIME FACTORS; TREATMENT OUTCOME;

EID: 24344467478     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Beral V, Peterman TA, Berkelman RL and Jaffe HW: Risk of Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335: 123-128, 1990.
2. Biggar RJ and Rabkin CS: The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 10: 997-1010, 1996.
3. Brodt HR, Kamps BS, Knupp B, Staszewski S and Helm EB: Changing incidence of AIDS-defining illness in the era of antiretroviral therapy. AIDS 11: 1731-1738, 1997.
4. Levine AM and Tulpule A: Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 37: 1288-1295, 2001.
5. Aboulafia DM: The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 117: 1128-1145, 2000.
6. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS: Identification of herpervirus-Iike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1859, 1994.
7. Schulz TF, Boshoff C and Weiss RA: HIV infection and neoplasia. Lancet 348: 587-591, 1996.
8. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, et al: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346: 799-802, 1995.
9. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW and Chang Y: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 10: 175-180, 1996.
10. Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B, Gudza I, Fitzpatrick L and Schooley RT: Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS 14: 2109-2116, 2000.
11. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ and Holmberg SD: Declining morbidity and mortality among patients with advanced human immune-deficiency virus infection. HIV Outpatients Study Investigators. N Engl J Med 338: 853-860, 1998.
12. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT and Montaner JS: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279: 450-454, 1998.
13. Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN and Myskowsky PL: Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor. AIDS 11: 261-262, 1997.
14. Lebbé C, Blum L, Pellet C, Blanchard G, Verola O, Morel P, Danne O and Calvo F: Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 12: F45-F49, 1998.
15. Cattelan AM, Calabrò ML, Gasperini P, A versa SM, Zanchetta M, Meneghetti F, De Rossi A and Chieco-Bianchi L: AIDS-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biological correlates of clinical outcome. J Natl Cancer Inst Monogr 28: 44-49, 2001.
16. Wit FW, Sol CJ, Renwick N, Roos MT, Pals ST, van Leeuwen R, Goudsmit J and Reiss P: Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 12: 218-219, 1998.
17. Boivin G, Gaudreau A and Routy JP: Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS 14: 1907-1910, 2000.
18. Gill J, Bourboulia D, Wilkinson J, Hayes P, Cope A, Marcelin AG, Calvez V, Gotch F, Boshoff C and Gazzard B: Prospective study of the effects of antiretroviral therapy on Kaposi's sarcomaassociated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 31: 384-390, 2002.
19. Krown SE, Metroka C and Wernz JC: Kaposi's sarcoma in the acquired immune, deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7: 1201-1207, 1989.
20. Krown SE, Testa MA and Huang J: AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group Staging Classsification. J Clin Oncol 15: 3085-3092, 1997.
21. Kennedy MM, Lucas SB, Jones RR, Howells DD, Picton SJ, Hanks EE, McGee JO and O'Leary JJ: HHV8 and Kaposi's sarcoma: a time cohort study. Mol Pathol 50: 96-100, 1997.
22. Calabrò ML, Fiore JR, Favero A, Lepera A, Saracino A, Angarano G, Schulz TF and Chieco-Bianchi L: Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 179: 1534-1537, 1999.
23. Aversa SM, Cattelan AM, Salvagno L, Meneghetti F, Francavilla E, Sattin L, Sasset L and Cadrobbi P: Chemoimmunotherapy of advanced AIDS-related Kaposi's sarcoma. Tumori 85: 54-59. 1999.
24. Dupin N, Rubin De Cervens V, Gorin I, Calvez V, Pessis E, Grandadam M, Rabian C, Viard JP, Huraux JM and Escande JP: The influence of highly active antiretroviral therapy on AIDSassociated Kaposi's sarcoma. Br J Dermatol 140: 875-881, 1999.
25. Dupont C, Vasseur E, Beauchet A, Aegerter P, Berthe H, De Truchis P, Zucman D, Rouveix E and Saiag P: Long term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS 14: 987-993, 2000.
26. Wilkinson J, Cope A, Gill J, Bourboulia D, Hayes P, Imami N, Kubo T, Marcelin A, Calvez V, Weiss R, Gazzard B, Boshoff C and Gotch F: Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type-1 infected patients receiving highly active antiretroviral therapy. J Virol 76: 2634-2640, 2002.
27. Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, Rezza G, Monini P and Ensoli B: NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur J Immunol 32: 2711-2720, 2002.
28. Nasti G, Talamini R, Antinori A, Martellotta F, Jacchetti G, Chiodo F, Ballardini G, Stoppini L, Di Perri G, Mena M, Tavio M, Vaccher E, D'Arminio Mont'orte A and Tirelli U; AIDS Clinical Trial Group Staging System in the Haart Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals: AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of patients naive from antiretrovirals. J Clin Oncol 21: 2876-2882, 2003.
29. Vaccher E, Di Gennaro G, Nasti G, Juzbasic S and Tirelli U: HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy. J Acquir Immune Defic Syndr 22: 407-408, 1999.
30. Esdaile B, Davis M, Portsmouth S, Sarker D, Nelson M, Gazzard B and Bower M: The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma. AIDS 16:2344-2347.2002.
31. Rizzieri DA, Liu J, Traweek ST and Miralles GD: Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 349: 775-776, 1997.
32. Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P and Ensoli B: HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi's sarcoma. Nat Med 8: 225-232, 2002.
33. Murdaca G, Campelli A, Setti M, Indiveri F and Puppo F: Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor. AIDS 16: 304-305, 2002.
34. Portsmouth S, Stebbing J, Gill J, Mandalia S, Bower M, Nelson M, Bower M and Gazzard B: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 11: F17-F22, 2003.
35. Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B and Rezza G: Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect 43:195-199,2001.
36. Emond JP, Marcelin AG, Dorent R, Milliancourt C, Dupin N, Frances C, Agut H, Gandjbakhch I and Calvez V: Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol 40: 2217-2219, 2002.